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Ankylosing Spondylitis and Sarcoidosis 
Coincidence or Association ? Case Report 
Review of the Literature 
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Summary We report a 25-year-old woman presenting with sarcoidosis and bi- 
lateral sacroiliitis. Her sarcoidosis related symptoms (malaise, cough and dysp- 
noea) improved dramatically under treatment with steroids but severe back pain 
persisted. Only seven similar cases have been described over the last 40 years and 
the question of a possible association between the two diseases has been raised. 
However, prevalence data from the literature and the apparent lack of genetic links 
are better arguments for coincidence than for association. 
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INTRODUCTION 
Since 1951, when Verstraeten (1) reported a first case 
with both sacroiliitis and sarcoidosis, six similar cases 
have been described in the literature, including only one 
female patient. Already Verstraeten and later Martin 
(2), Deshayes (3), Cabanel (4), Blanchon (5) and Ger- 
ster (6) raised the question about a possible association 
between the two diseases. We report another case of a 
25-year-old woman presenting typical findings of sarcoi- 
dosis and a six-month istory of bilateral iliosacral pain. 
The probability of an association between the two dis- 
eases is discussed. 
CASE REPORT 
The personal history of the 25-year-old female patient 
revealed a single episode of lumbar pain on motion ir- 
radiating to both legs in 1985; X-rays showed a 
spondylolisthesis of L5 on S1. Being in good health until 
February 1990, the patient hen noted pain in her mid- 
back and in the area of the right sacroiliac joint irradi- 
ating to the right buttock. Maximum pain regularly in- 
terrupted her sleep between one and three o'clock in the 
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morning. And low back stiffness was present for about 
two hours after rising. Further symptoms included recur- 
rent fever up to 38~ poor appetite, and weight loss of 
10 kilos within a six-month period. In March 1990 anky- 
losing spondylitis was diagnosed by a practicing rheuma- 
tologist based on symptoms, clinical findings and inflam- 
matory erosive X-ray changes of both sacroiliac joints 
(Fig. 1). HLA-B27 was positive, an ileocolonoscopy in- 
cluding biopsy and histology examinations ofboth the il- 
eum and colon were normal, the erythrocyte sediment- 
ation rate (ESR) was 16 mm after 1 hour (Westergren). 
There was no evidence of presence of another form 
among the seronegative spondyloarthropathies. In June 
1990 the patient was referred to our inpatient clinic for 
evaluation because of severe general malaise and in- 
creasing pain resistent o NSAID's (indomethacin, di- 
clofenac, ibuprofen, phenylbutazone). Upon admission 
the patient reported severe low back pain irradiating to 
the buttocks, dyspnoea and palpitation when climbing 
two flights of stairs, and a nonproductive cough. The 
clinical examination revealed limited painful motion of 
both lumbar (Schober Index 10/11 cm) and thoracic 
spine in all directions. The thoracic excursion was lim- 
ited to 80/83 cm. The sacroiliac provocation tests were 
strongly positive on both sides. No other significant find- 
ings were present. Laboratory screening showed an ESR 
of 34 mm after 1 hour, a C-reactive protein of 36.1 mg/1 
(upper limit 10 mg/1), a slight thrombocytosis of 443 x 
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Fig. 1 : Bilateral sacroiliitis on ap view. 
Table I : Case reports with both ankylosing spondylitis and sarcoidosis 
Author Sex Age Musculoskeletal symptoms Manifestations of sarcoidosis Time Therapy Course 
(year of pub- (age at onset) (age at onset) interval 
lication) (months) 
Verstraeten m 36 ankylosing spondylitis bihilar lymphadenopathy 72 none 
(1951) (30) (36) 
Martin m 58 ankylosing spondylitis bihilar lyrnphadenopathy 84(?) none 
(1953) (45 ?) (38) 
Deshayes m 48 ankylosing spondyfitis bihilar lymphadenopathy, ? prednisolone 
(1%5) (40) pulmonary fibrosis 
(4O) 
Brun f 34 left sacroiliitis bihilar lymphadenopathy, 8 steroids, chemotherapy 
(1966) (34) pulmonary fibrosis 
(33) 
Cabanel m 40 bilateral sacroiliitis bihilar iymphadenopathy, 0 (?) chemotherapy, phenylbuta- 
(1973) (24) pulmonary fibrosis zone 
(24) 
Blanchon m 24 left pulmonary fibrosis, parotitis, 12 prednisone 
(1976) sacroiliitis peripheral iymphadenopathy 
(21) (18) 
Gerster m 27 bilateral sacroiliitis, relapsing bihilar lymphadenopathy, 6 phenylbutazone 
(1981) " uveitis erythema nodosum, arthritis 
(24) left ankle (25) 
? 
subsequent pulmonary fibro- 
sis 
less back pain under steroids 
subsequent oligoarthritis 
(knee, hip) and ankylosing 
spondylitis 
subsequent bony cysts (hand, 
feet), skin ulceration, epid- 
idymitis 
subsequent bihilar lymphade- 
nopathy; left ankle arthritis 
and erythema nodosum dis- 
appear; low back pain per- 
SlSts. 
103/~tl and normocalcaemia (the reported incidence of 
hypercalcaemia n sarcoidosis varies from 2 to 63%, (7)). 
The angiotensin converting enzyme level was also within 
normal limits (44% of patients with bihilar lymphade- 
nopathy but normal lung parenchyma have angiotensin 
converting enzyme levels within ormal limits, (8)). On 
chest X-ray (Fig. 2) a bihilar lymphadenopathy and a 
normal lung parenchyma were found and confirmed by 
computerized tomography. Pulmonary function tests re- 
vealed a moderate restrictive lung disease with a mild 
obstructive component, and a slightly decreased carbon 
monoxide diffusing capacity. Transbronchial biopsy 
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showed multiple noncaseating granulomas with epithe- 
loid and multinucleated giant cells (Fig. 3), and bron- 
chioalveolar lavage yielded an increased helper T-cell to 
supressor T-cell ratio of 4.5:1 (a ratio of over 3.5:1 yield- 
ed a sensitivity of 53.2% and a specificity of 92.8% in 
accord with reference 9). The ratio in the blood was 
2.1:1. All acid-fast and fungal stains and cultures were 
negative. Electrocardiogram, echocardiography, and 
ophthalmologic examination were normal. Under treat- 
ment with prednisone starting at 50 mg per day, general 
malaise, dyspnoea and cough disappeared, and ESR 
(6 mm/1 hour), C-reactive protein (16 rag/l), pulmonary 
function tests and bihilar lymphadenopathy returned to 
normal. After a follow-up of one year, however, the pa- 
tient still suffers from severe low back pain exacerbating 
at night despite high doses of indomethacin. A tissue 
typing for the HLA antigens revealed thefollowing re- 
suits: A1, - ;  B8, 27; DR3, 4 (DRw52, 53; DQw2, 3). 
DISCUSSION 
Fig. 2: Chest roentgenogram showing bilateral hilar 
lymphadenopathy. 
This is a report of a 25-year-old woman with ankylos- 
ing spondylitis who developed symptomatic pulmonary 
sarcoidosis. Despite prompt improvement of the sarcoi- 
dosis related malaise, dyspnoea nd cough as well as the 
ESR under treatment with prednisone, persistent in- 
Fig. 3: Transbronchial biopsy showing noncaseating granuloma with epitheloid cells including amultinuclear giant cell. 
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f lammatory back pain was noted despite addit ional  
NSAID therapy. This di f ference between the therapeu-  
tic responses of pu lmonary and musculoskeletal  symp- 
toms suggests the presence of di f ferent pathogenet ic  
mechanisms involved in the two disorders.  Based on ep- 
idemiological  data there is no reason to assume an as- 
sociation of the two entit ies each having a relatively high 
prevalence. The prevalence of  ankylosing spondyl it is is 
reported as 1 per  1000 populat ion (10), and the prev- 
alence of sarcoidosis varies from 0.04 in Spain to 64 per  
1000 populat ion in Sweden (11). Therefore,  based on 
pure coincidence, prevalence data for the two disorders 
are to be expected in the order  of 0.00004 to 0.064 per  
1000, the numbers being even higher if associat ion of the 
two diseases is assumed. In the l i terature,  however, only 
seven similar cases were repor ted over a per iod of 39 
years indicating the lack of an associat ion between sar- 
coidosis and ankylosing spondylit is ((1-6,12), Table I). 
A genet ica l ly-determined predisposi t ion to develop ei- 
ther sarcoidosis or ankylosing spondylit is has been noted 
in certain groups of patients.  HLA-DR5 was signif icant- 
ly increased in an endemic  cluster of pat ients  with sar- 
coidosis in Germany (13,14), and HLA-B8 has been as- 
sociated with acute sarcoidosis - re lated arthrit is (15) 
and with spontaneous resolut ion (16). HLA-B8  and 
HLA-DR3 have been associated with acute onset of sar- 
coidosis with arthrit is (17,18). On the other  hand, there 
is a clear associat ion f  ankylosing spondyl it is with HLA-  
B27 (19). However,  no common genetic l inks have been 
ident i f ied for the two disorders.  Interest ingly,  in our pa- 
t ient we found HLA-B27 as well as HLA-B8  and HLA-  
DR3 to be positive. The presence of the typical HLA 
specif icit ies for both diseases may indicate the coexist- 
ence of two independent  disease processes. 
In conclusion, response to therapy,  prevalence data 
from the l i terature and the apparent  lack of genet ic  l inks 
are bet ter  arguments for coincidence than for associa- 
tion. 
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